Treace Medical Concepts Inc. (TMCI) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Treace Medical Concepts I... (TMCI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

8.00

-0.36 (-4.31%)

At close: Jan 14, 2025, 3:59 PM

8.01

0.12%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	6.52
Market Cap	498.38M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.99
PE Ratio (ttm)	-8.08
Forward PE	n/a
Analyst	Hold

Ask	8.8
Volume	419,505
Avg. Volume (20D)	489,575
Open	8.45
Previous Close	8.36
Day's Range	7.74 - 8.57
52-Week Range	3.92 - 15.98
Beta	undefined

About TMCI

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers pro...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Apr 23, 2021

Employees 516

Stock Exchange NASDAQ

Ticker Symbol TMCI

Website https://www.treace.com

Analyst Forecast

According to 7 analyst ratings, the average rating for TMCI stock is "Hold." The 12-month stock price forecast is $8, which is a decrease of 0.00% from the latest price.

Buy 14.29%

Hold 85.71%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Treace Medical Concepts Inc. is scheduled to release its earnings on Feb 27, 2025, after market closes.
Analysts project revenue of $67.01M, reflecting a 7.71% YoY growth and earnings per share of -0.02, making a -80.00% decrease YoY.

Why Price Moved

2 days ago · Source

+14.52%

Treace Medical Concepts shares are trading higher ... Unlock content with Pro Subscription

2 weeks ago · Source

+8.14%

Treace Medical Concepts shares are trading higher after Lake Street initiated coverage on the stock with a Buy rating and announced a price target of $14.5.

News

6 days ago · businesswire.com

The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors.

1 week ago · zacks.com

TMCI Stock May Gain From the Limited Release of the Percuplasty System

Treace Medical announces the limited market release of the Percuplasty Percutaneous 3D Bunion Correction System, targeting the in-demand bunion surgery market.

2 months ago · seekingalpha.com

Treace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call Transcript

Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2024 Earnings Call November 5, 2024 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer Mark Hai...

2 months ago · zacks.com

Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.28 per share a year ago.

2 months ago · businesswire.com

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Treace Medical Co...